Screening Biologist (Senior/Principal)
Make your mark in developing field-leading oral macrocycle design
Backed by leading life sciences investors such as Novo Holdings and Forbion, Orbis is empowered to invest in groundbreaking technologies like the field-leading oral macrocycle design and development platform, nGen. Orbis Medicines operates at the intersection of science and technology, integrating cutting-edge tools like artificial intelligence (AI) and machine learning (ML) to accelerate the drug discovery process.
With established facilities and highly skilled professionals in Lausanne, Switzerland, Orbis Medicines is establishing discovery capabilities at a new Copenhagen site. The site is expected to house a team of 15 experienced professionals, bringing the total workforce to 30, including the Lausanne site.
As Screening Biologist at Orbis Medicines, you will join the newly established team in Copenhagen, Denmark, and contribute to discovering and developing innovative therapeutic solutions.
With direct report to the VP, Discovery Biology, you take a driving role in the startup and equipment of the lab facilities, setting up effective workflow procedures in an active lab role.
Your main tasks include:
- Target research and identification of suitable assay methodologies.
- Development and adaptation of biochemical and cellular test systems to miniaturised format.
- High throughput screening of compounds.
- Evaluation of data and logging of experimental methods.
- Planning and coordination of activities across different departments.
Your qualifications include more than eight years of practical laboratory experience, preferentially from the pharma industry, including experience with high-throughput screening, cell culture techniques and/or assay development.
You have a PhD in a relevant life science discipline and multi-year post-doc experience.
You are driven to expand knowledge and capabilities within the team. You are precise, independent, and results-driven, committed to quality. You are a highly motivated, proactive, and flexible team player. You are adaptable to changing priorities and resilient in managing challenges. You have strong communication skills to foster collaboration and feedback across teams.
Orbis Medicines offers a unique opening to join a growing start-up and opportunities to grow in an innovative, collaborative, and passionate environment that will pioneer a new era for oral macrocycle drug discovery.
Travelling: Limited.
Domicile: Orbis Medicines’ facility in Copenhagen.
At Unique Human Capital, we are committed to promoting diversity and including all perspectives. Thus, we encourage all qualified candidates to apply for the position. All applications must be in English and are treated confidentially.
Orbis Medicines is a biotechnology company focused on pioneering a new oral macrocycle drug discovery era. Macrocycles are a large and diverse family of compounds with highly desirable therapeutic properties. The Orbis nGen platform is designed to systematically explore the macrocycle chemical space using a highly automated chemistry platform and deliver oral macrocycle drug candidates – nCycles – suitable for intra- and extracellular targets. Orbis’ programs are focused on high-value oral alternatives to blockbuster biologic drugs and targets challenging for established modalities. Orbis Medicines was founded by Novo Holdings.
Read more at http://www.orbismedicines.com.
Do you have any questions about the position?
Then feel free to contact the following people directly. All applications must be in English and are treated confidentially.
